Unlap, e tripeptide, GHK, induces programmed cell death in SH-SYY neuroblastoma cells, Journal of Biotechnology & Biomaterials,vol.,article,

Evidence from TRIUMPH-4 and TRIUMPH-1: Mostly rated as "mild" by participants Rarely led to discontinuation (12%) No progression to serious neurological issues Reversible when medication stopped (in Phase 2 extension) When to Call Your Doctor About Dysesthesia Call if you experience: Severe pain (not just tingling) Progressive worsening despite dose stability Loss of coordination or balance Weakness in hands or feet Symptoms interfering with daily life Likely benign if: Mild tingling only Stable or improving over time No pain or weakness Managing Nausea: The Most Common Side Effect Why GLP-1 Medications Cause Nausea GLP-1 slows gastric emptying food stays in stomach longer Longer gastric residence feeling of fullness (desired!) or nausea (not desired) Brain signaling changes nausea sensation Good news: This is the SAME mechanism producing weight loss
You notice bleeding, itching, or new irritation after a bowel movement
Phase 3 RCT (2024) : Chinese multicenter trial (n=458) demonstrating significant improvement in modified Toronto Clinical Neuropathy Score with ALC 1,500 mg/day vs
This shift toward more mindful spending and living shows that GLP-1s could be influencing habits far beyond the dinner plate